NCT07156760

Brief Summary

Introduction A large number of stroke patients develop spasticity in the upper and lower extremities, which is one of the clinical signs of damage to motor neuron 1, causing abnormal postures and movement patterns due to motor neuron hyperexcitability and rheological alterations in the affected muscles. These alterations limit the use of the arm and leg, restricting their use in functional activities and affecting the quality of life and social participation of users. In recent years, the Heckmann scale has been used to evaluate spastic muscle alterations by ultrasound; however, evidence is limited regarding its benefits as an assessment tool for spastic hypertonia. Objective To describe the morphological characteristics of spastic muscles in the lower extremities using ultrasound examination in subjects after stroke. Method A prospective, multicenter descriptive study will be conducted. The sample will be non-probabilistic, consisting of 80 subjects who meet the eligibility criteria and provide informed consent. Analysis of results Using the SPSS 27 program, a descriptive analysis will be performed using statistical indices of central tendency, dispersion, and distribution according to the measurement scale of each variable. The normality of the distribution of continuous variables will be investigated. In addition, a bivariate correlation analysis (ANOVA) will be performed. The significance level will be 0.05. Expected Results It will provide updated evidence in the field of assessing the state of spastic muscles in subjects with neurological damage, a situation that will guide the therapeutic process and may improve the patient's prognosis and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 5, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

August 10, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

strokeSpasticity MuscleUltrasound diagnostics

Outcome Measures

Primary Outcomes (1)

  • Spasticity

    Modified Ashworth Scale (MAS) The scale measures resistance during passive soft-tissue stretching. Lower values mean less spasticity Scoring: 0 - No increase in muscle tone. 1 - Slight increase in muscle tone, manifested by a catch and release at the end of the range of motion when the affected part(s) are moved in flexion or extension. 1+ - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of motion. 2 - More marked increase in muscle tone through most of the range of motion, but affected part(s) easily moved. 3 - Considerable increase in muscle tone, passive movement difficult. 4 - Affected part(s) rigid in flexion or extension.

    Outcome measure: Day 1, prior to the ultrasound scan. The results report will be issued 1 month after the analysis, sharing the analysis with participating centers and patients. On average, 1 year after the start of the study.

Secondary Outcomes (2)

  • Spasticity

    Day 1, prior to the ultrasound scan. The results report will be issued 1 month after the analysis, sharing the analysis with participating centers and patients. On average, 1 year after the start of the study.

  • Morphological characteristics

    Day 1, after the initial assessment. 5 patients per day, completing 15 per week at each center. Total intervention time, through study completion, an average of 6 months.

Interventions

Ultrasound diagnosticsDIAGNOSTIC_TEST

Non-invasive ultrasound evaluation of the upper limb on the hemiplegic side (Ekipomed Portable Ultrasound) to determine its pathological morphology (thickness, fiber orientation, and echogenicity) using the modified Heckmatt scale. This procedure will be performed by a physician who is an expert in muscle ultrasound.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult stroke patients with spasticity.

You may qualify if:

  • Patients over 18 years of age with a history of stroke more than three months ago.
  • Who are undergoing or have undergone some type of rehabilitation in the acute and/or subacute stage.
  • Who present spastic hypertonia in the upper and lower extremities detectable by Ashworth and Tardieu assessment.
  • Presence of spastic pattern according to Hefter classification.
  • Who agree to participate in the study and sign the consent form.

You may not qualify if:

  • Structural joint involvement that prevents tone assessment.
  • Patients who have been injected with antispastic drugs in the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidad de La Frontera

Temuco, Araucania, 4780000, Chile

Location

Universidad de La Frontera

Temuco, 478000, Chile

Location

Related Publications (3)

  • Doussoulin A, Rivas R, Sabelle C. [Hospital discharges due to stroke in the period 2001-2010 in a southern Chilean region]. Rev Med Chil. 2016 May;144(5):571-6. doi: 10.4067/S0034-98872016000500003. Spanish.

    PMID: 27552006BACKGROUND
  • Trompetto C, Marinelli L, Mori L, Pelosin E, Curra A, Molfetta L, Abbruzzese G. Pathophysiology of spasticity: implications for neurorehabilitation. Biomed Res Int. 2014;2014:354906. doi: 10.1155/2014/354906. Epub 2014 Oct 30.

    PMID: 25530960BACKGROUND
  • Li S. Spasticity, Motor Recovery, and Neural Plasticity after Stroke. Front Neurol. 2017 Apr 3;8:120. doi: 10.3389/fneur.2017.00120. eCollection 2017.

    PMID: 28421032BACKGROUND

MeSH Terms

Conditions

StrokeMuscle Spasticity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Arlette P. Doussoulin, PhD

    Universidad de La Frontera

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 10, 2025

First Posted

September 5, 2025

Study Start

March 1, 2025

Primary Completion

April 1, 2025

Study Completion

December 31, 2025

Last Updated

April 28, 2026

Record last verified: 2026-04

Locations